No idea but I"m sure that's being looked at and would not yet be available. If that's the case you should have many score improvements >4 like last time whether that be labeled as placebo or bryostatin. If you see scores like that it may be worth a look. If not then it would fall in line more with poor drug efficacy for whatever reason. Certainly a long shot. I'm leaning more for a reason the science failed than an error on the company we are paying 10 million dollars to.
you’re giving the SIB numbers too much weight. The error margin is 3.7. When MMSE is not measurable they use SIB which gives them another 0-40 scale. Below the error margin just means zero.